Telegram Group & Telegram Channel
Immunohematology Course

*اليوم إن شاء الله بداية الكورس الساعة 7 مساء بتوقيت السودان*

🔷 *فقط ب ألفين للدفعة دي بدلا عن 10 ألف*

🔷طريقة الدراسة: الكورس في شكل تسجيلات صوتية مشروح من مراجع

🔷للتسجيل والاستفسار: 0110753218

*Contents of immunohematology Course*

🟣ABO blood grouping system
🟣Rh blood grouping system
🟣Minor blood grouping system
🟣Pre transfusion testing
🟣Compatibility  testing
🟣Donor screening
🟣Blood components and their administration
🟣Apheresis
🟣 Hemolytic transfusion reaction
🟣Hemolytic disease of fetus and newborn



tg-me.com/OnlineLecturesMLS/965
Create:
Last Update:

Immunohematology Course

*اليوم إن شاء الله بداية الكورس الساعة 7 مساء بتوقيت السودان*

🔷 *فقط ب ألفين للدفعة دي بدلا عن 10 ألف*

🔷طريقة الدراسة: الكورس في شكل تسجيلات صوتية مشروح من مراجع

🔷للتسجيل والاستفسار: 0110753218

*Contents of immunohematology Course*

🟣ABO blood grouping system
🟣Rh blood grouping system
🟣Minor blood grouping system
🟣Pre transfusion testing
🟣Compatibility  testing
🟣Donor screening
🟣Blood components and their administration
🟣Apheresis
🟣 Hemolytic transfusion reaction
🟣Hemolytic disease of fetus and newborn

BY HEMATOLOGY WORLD🔬


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/OnlineLecturesMLS/965

View MORE
Open in Telegram


HEMATOLOGY WORLD Telegram | DID YOU KNOW?

Date: |

Importantly, that investor viewpoint is not new. It cycles in when conditions are right (and vice versa). It also brings the ineffective warnings of an overpriced market with it.Looking toward a good 2022 stock market, there is no apparent reason to expect these issues to change.

That strategy is the acquisition of a value-priced company by a growth company. Using the growth company's higher-priced stock for the acquisition can produce outsized revenue and earnings growth. Even better is the use of cash, particularly in a growth period when financial aggressiveness is accepted and even positively viewed.he key public rationale behind this strategy is synergy - the 1+1=3 view. In many cases, synergy does occur and is valuable. However, in other cases, particularly as the strategy gains popularity, it doesn't. Joining two different organizations, workforces and cultures is a challenge. Simply putting two separate organizations together necessarily creates disruptions and conflicts that can undermine both operations.

HEMATOLOGY WORLD from in


Telegram HEMATOLOGY WORLD🔬
FROM USA